SeekingAlpha · Jun 23, 2026
InfuSystem: A Good Time To Buy Before A Potential Breakout
InfuSystem (INFU) stock: buy case on 11.6% FCF yield, margin gains, low EV/EBITDA, and ERP efficienciesâplus key risks. See more details here.
IN
AMEX · INFU
InfuSystem Holdings, Inc.
Healthcare · Medical - Instruments & Supplies
$13.49
Down-$0.22 (-1.63%)
Updated Oct 6, 2026, 10:38 PM
SID Score
5.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 186.69M
- P/E ratio
- 34.53
- Dividend yield
- 0.00%
- 52-week range
- $7.29 – $13.85
- Volume
- 137.73K
- Avg. volume
- 191.92K
Price performance · INFU
INFU price history
1M range · 0 trading sessions · Daily adjusted prices
INFU does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest INFU news
The latest Smart Investors Daily articles mentioning INFU.
Stock researchCompany · Overview
Company
Market Activity
Research & News
INFU research
Overview
Company profile and research snapshot.
Company profile
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $14.00
- Implied upside
- —
- Analysts
- 11
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 5, 2026 | B. Riley Securities | Buy | — |
| Feb 25, 2026 | Roth Capital | Buy | — |
| Nov 5, 2025 | Roth Capital | Buy | — |
| Jul 22, 2025 | Roth Capital | Buy | — |
| Sep 26, 2024 | B. Riley Securities | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Feb 25, 2026
Roth Capital Reiterates Buy on InfuSystems Holdings, Raises Price Target to $15
Roth Capital analyst Kyle Bauser reiterates InfuSystems Holdings (AMEX:INFU) with a Buy and raises the price target from $14 to $15.
ChartMill · Feb 24, 2026
InfuSystem Holdings Inc (INFU) Reports Strong Earnings Beat and Margin Expansion in Q4 2025
InfuSystem reports strong 2025 earnings and margin growth, despite a slight revenue miss. The company restructured a key contract to boost future profitability.
SeekingAlpha · Feb 24, 2026
InfuSystem Holdings, Inc. (INFU) Q4 2025 Earnings Call Transcript
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
